ICMR will involve Private Labs for COVID-19 tests

New Delhi: ICMR (Indian Council of Medical Research) has decided to involve private labs for COVID-19. As of today 72 ICMR labs are available, 50 additions will be by the end of this week.

Indian Council of Medical Research (ICMR), the apex health research body of India has activated more laboratories to test for COVID-19 and revised the testing criteria for the same.

The Council has equipped 72 of its laboratories to test for the pandemic disease. In addition to these labs 49 more laboratories under organizations like Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT), and Defence Research, Development Organisation (DRDO) would be equipped to test for COVID19 by end of this week. ICMR will also be setting up two testing locations (NCR and Bhubaneswar) for high throughput diagnostic systems for exponentially increasing rapid diagnosing of COVID-19.

These systems can test up to 1400 samples in a day. ICMR is having a dialogue with high-quality private labs that includes labs accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL) to understand the modalities of increasing access to the test in the endeavour to prepare for future.

ICMR has also revised the testing criteria for COVID-19 under which an individual should home quarantine themselves for 14 days if they qualify for the following conditions:

1.Direct close physical contact of laboratory confirmed positive case 2. History of travel in last 14 days to high risk COVID-19 affected countries

If the person develops symptoms like fever, cough and difficulty in breathing they should immediately contact the Ministry of Health and Family Welfare helpline for testing. If the person is asymptomatic, they do not require a laboratory test. In addition to these conditions, if a healthcare worker managing respiratory distress/Severe Acute Respiratory Illness shows symptoms of acute respiratory illness they should get a laboratory test for COVID-19. If these cases are tested positive, then they should be isolated and treated as per the standard protocols.

Prof (Dr) Balram Bhargava, Secretary, Department of Health Research & Director General, ICMR, said “We at ICMR are regularly monitoring for community transmissions. Our labs are looking at random samples of patients who suffer from influenza like illnesses/ Severe Acute Respiratory Illness for presence of the COVID-19. So far, these results are negative thus implying that India has not reached the stage for community transmissions”

Related Posts

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines